| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0079 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |